http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108904499-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-04 |
| filingDate | 2018-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108904499-B |
| titleOfInvention | A kind of medical usage for the tetrahydro isoquinoline compound that hydroxyl replaces |
| abstract | Application the invention mainly relates to a series of synthesis of the compound of structures containing tetrahydroisoquinoline and its in the field of medicine.Specifically, being able to suppress growth of tumour cell and transfer the present invention relates to a series of tetrahydroisoquinoline structural compounds, there is application prospect to prevention or treating cancer. |
| priorityDate | 2018-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.